The estimated Net Worth of Fintan Keegan is at least $6.03 Milion dollars as of 8 July 2014. Fintan Keegan owns over 1,991 units of Jazz Pharmaceuticals plc stock worth over $3,337,878 and over the last 12 years Fintan sold JAZZ stock worth over $2,695,001.
Fintan has made over 6 trades of the Jazz Pharmaceuticals plc stock since 2013, according to the Form 4 filled with the SEC. Most recently Fintan sold 1,991 units of JAZZ stock worth $308,605 on 8 July 2014.
The largest trade Fintan's ever made was selling 11,674 units of Jazz Pharmaceuticals plc stock on 7 March 2013 worth over $882,438. On average, Fintan trades about 2,356 units every 49 days since 2012. As of 8 July 2014 Fintan still owns at least 31,750 units of Jazz Pharmaceuticals plc stock.
You can see the complete history of Fintan Keegan stock trades at the bottom of the page.
Fintan's mailing address filed with the SEC is C/O JAZZ PHARMACEUTICALS PLC, CONNAUGHT HOUSE, 1 BURLINGTON RD, FL. 4, DUBLIN 4, L2, .
Over the last 17 years, insiders at Jazz Pharmaceuticals plc have traded over $1,513,676,247 worth of Jazz Pharmaceuticals plc stock and bought 1,319,315 units worth $25,188,964 . The most active insiders traders include Michael W Michelson, Patrick G Enright oraz Jp Iii Llckkr Partners Iii,.... On average, Jazz Pharmaceuticals plc executives and independent directors trade stock every 11 days with the average trade being worth of $5,162,934. The most recent stock trade was executed by Mary Elizabeth Henderson on 6 September 2024, trading 1,410 units of JAZZ stock currently worth $152,703.
jazz pharmaceuticals plc (nasdaq: jazz) is an international biopharmaceutical company focused on improving patients’ lives by identifying, developing and commercializing meaningful products that address unmet medical needs. we are a diverse company of over 875 employees focused on portfolio of products and/or product candidates in the areas of sleep, hematology/oncology and pain. founded in 2003 and headquartered in dublin, ireland, jazz pharmaceuticals has u.s. offices in palo alto, ca and philadelphia, pa, and has offices in various other locations in europe. the company’s maintains a highly collaborative and entrepreneurial culture where employees focus on how they accomplish success as well as what is done to accomplish results by operating in accordance with the company’s core values: integrity, collaboration, passion, innovation and the pursuit of excellence. we plan to build upon our portfolio of products through acquisition and/or in-licensing activities, and leveraging our uni
Jazz Pharmaceuticals plc executives and other stock owners filed with the SEC include: